158 related articles for article (PubMed ID: 3288125)
21. The role of Langerhans cells and keratinocytes in epidermal immunity.
Choi KL; Sauder DN
J Leukoc Biol; 1986 Mar; 39(3):343-58. PubMed ID: 2418143
[TBL] [Abstract][Full Text] [Related]
22. Distribution of Langerhans cells and HLA class II molecules in prostatic carcinomas of different histopathological grade.
Bigotti G; Coli A; Castagnola D
Prostate; 1991; 19(1):73-87. PubMed ID: 1876538
[TBL] [Abstract][Full Text] [Related]
23. In cutaneous T-cell lymphoma, class II MHC molecules on CD1+ antigen-presenting cells are upregulated in involved compared with uninvolved epidermis.
Hansen ER; Bang B; Larsen JK; Vejlsgaard GL; Baadsgaard O
Br J Dermatol; 1994 Dec; 131(6):780-8. PubMed ID: 7531998
[TBL] [Abstract][Full Text] [Related]
24. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation.
Meunier L; Bohjanen K; Voorhees JJ; Cooper KD
J Invest Dermatol; 1994 Dec; 103(6):775-9. PubMed ID: 7798614
[TBL] [Abstract][Full Text] [Related]
25. Functional and phenotypic analysis of isolated human Langerhans cells and indeterminate cells.
Czernielewski JM; Schmitt D; Faure MR; Thivolet J
Br J Dermatol; 1983 Feb; 108(2):129-38. PubMed ID: 6186266
[TBL] [Abstract][Full Text] [Related]
26. Differing cell surface distribution of human leukocyte antigen-DR molecules on epidermal Langerhans cells and eccrine duct cells.
Imayama S; Yashima Y; Hori Y
J Histochem Cytochem; 1992 Aug; 40(8):1191-6. PubMed ID: 1619281
[TBL] [Abstract][Full Text] [Related]
27. Quantitative and three-dimensional analysis of human Langerhans cells in epidermal sheets and vertical skin sections.
Emilson A; Scheynius A
J Histochem Cytochem; 1995 Oct; 43(10):993-8. PubMed ID: 7560889
[TBL] [Abstract][Full Text] [Related]
28. Expression of HLA-DR and T6 antigens on keratinocytes and dendritic cells. A comparative immunohistochemical study.
Drijkoningen M; De Wolf-Peeters C; van den Oord JJ; Degreef H; Desmet V
Arch Pathol Lab Med; 1986 Apr; 110(4):321-5. PubMed ID: 2420303
[TBL] [Abstract][Full Text] [Related]
29. Quantification of CD1a, HLA-DR, and HLA class I expression on viable human Langerhans cells and keratinocytes.
Meunier L; Vian L; Lagoueyte C; Lavabre-Bertrand T; Duperray C; Meynadier J; Cano JP
Cytometry; 1996 Dec; 26(4):260-4. PubMed ID: 8979024
[TBL] [Abstract][Full Text] [Related]
30. An immunocytochemical study of MHC class I expression on human Langerhans cells and melanocytes.
Moseley RP; Brown JI; Auld J; Mumtaz H; Rainey AJ; Kirkham N; Gelsthorpe K; Masters R; Smith ME
J Pathol; 1997 Apr; 181(4):419-25. PubMed ID: 9196440
[TBL] [Abstract][Full Text] [Related]
31. Epidermal Langerhans cells, dermal dendritic cells, and keratinocytes in viral lesions of skin and mucous membranes: an immunohistochemical study.
Drijkoningen M; De Wolf-Peeters C; Degreef H; Desmet V
Arch Dermatol Res; 1988; 280(4):220-7. PubMed ID: 2466441
[TBL] [Abstract][Full Text] [Related]
32. Immunogold labelling of epidermal Langerhans cells on tissue sections of normal human skin.
De Panfilis G; Manara GC; Ferrari C
Br J Dermatol; 1986 Sep; 115(3):351-6. PubMed ID: 3530311
[TBL] [Abstract][Full Text] [Related]
33. OKT6 is not superior to HLA-DR or ATPase as a marker for Langerhans' cells in normal human epidermis.
Liu HH; Schroeter AL; Muller SA
Clin Exp Dermatol; 1986 May; 11(3):229-37. PubMed ID: 2943537
[No Abstract] [Full Text] [Related]
34. Downregulation of class II molecules on epidermal Langerhans cells in Lyme borreliosis.
Silberer M; Koszik F; Stingl G; Aberer E
Br J Dermatol; 2000 Oct; 143(4):786-94. PubMed ID: 11069457
[TBL] [Abstract][Full Text] [Related]
35. Ultrastructural immunogold labelling of human Langerhans cells enriched epidermal cell suspension.
Schmitt D; Faure M; Dezutter-Dambuyant C; Tuffery D
Arch Dermatol Res; 1984; 276(1):27-32. PubMed ID: 6367673
[TBL] [Abstract][Full Text] [Related]
36. Interferon enhancement of HLA-DR antigen expression on epidermal Langerhans cells.
Berman B; Duncan MR; Smith B; Ziboh VA; Palladino M
J Invest Dermatol; 1985 Jan; 84(1):54-8. PubMed ID: 2578172
[TBL] [Abstract][Full Text] [Related]
37. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines.
Tokura Y; Yagi J; O'Malley M; Lewis JM; Takigawa M; Edelson RL; Tigelaar RE
J Invest Dermatol; 1994 Jan; 102(1):31-8. PubMed ID: 8288908
[TBL] [Abstract][Full Text] [Related]
38. HLA-DQA2 and HLA-DQB2 genes are specifically expressed in human Langerhans cells and encode a new HLA class II molecule.
Lenormand C; Bausinger H; Gross F; Signorino-Gelo F; Koch S; Peressin M; Fricker D; Cazenave JP; Bieber T; Hanau D; de la Salle H; Tourne S
J Immunol; 2012 Apr; 188(8):3903-11. PubMed ID: 22407913
[TBL] [Abstract][Full Text] [Related]
39. Regulation of immune activity by mild (fever-range) whole body hyperthermia: effects on epidermal Langerhans cells.
Ostberg JR; Patel R; Repasky EA
Cell Stress Chaperones; 2000 Nov; 5(5):458-61. PubMed ID: 11189452
[TBL] [Abstract][Full Text] [Related]
40. Systemic treatment with anti-CD40 antibody stimulates Langerhans cell migration from the skin.
Jolles S; Christensen J; Holman M; Klaus GB; Ager A
Clin Exp Immunol; 2002 Sep; 129(3):519-26. PubMed ID: 12197894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
